NME1 and colorectal cancer: For example, miR-28-5p inhibits EMT by upregulating E-cadherin or downregulating NM23-H1 in colorectal cancer (CRC) [69], nasopharyngeal carcinoma (NPC) [55], and ovarian cancer (OC) [89], thereby reducing cell migration and invasiveness.